search
Back to results

Service Development of POCUS in the IBD Clinic

Primary Purpose

Inflammatory Bowel Diseases

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Point-of-care ultrasound
Sponsored by
University College, London
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Inflammatory Bowel Diseases focused on measuring Intestinal ultrasound

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 16 years or above Attending IBD clinic face-to-face Able to give informed consent. Belonging to one of the following groups: New patients with high clinical suspicion of IBD Known UC/IBD-U and possible flare Known Crohn's and possible flare Known IBD and assessing response to a new medication or following surgery Known IBD and clinician planning endoscopic or radiological investigations Exclusion Criteria: Inflammatory bowel disease limited to proctitis with no clinical suspicion of extension

Sites / Locations

  • University College London Hospitals NHS TrustRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Point-of-care Ultrasound

Arm Description

Participant will follow standard of care

Participant will receive point-of-care ultrasound at time of clinic appointment and clinician will use result to inform treatment decision

Outcomes

Primary Outcome Measures

Compare time to definitive IBD-related treatment initiation with the use of POCUS compared to standard of care
Time in days for when a new medication is started, dose changed, medication stopped, or surgery performed following the clinic appointment

Secondary Outcome Measures

Does point of care ultrasound change clinical decision making in the IBD clinic
Does the clinical decision made before ultrasound differ from that following ultrasound.
Compare sensitivity and specificity of POCUS to identify active disease with standard of care investigations (MRI, ultrasound, endoscopy)
Using formalised imaging or endoscopy as gold standard for determining disease activity, compare findings on POCUS to determine sensitivity and specificity
Compare healthcare resource utilisation including outpatient appointments, need for further investigations and admissions in patients receiving POCUS or standard of care
Using NHS cost tariffs, estimated costs for participants following standard of care to those receiving POCUS over the year following enrolment
Compare findings at POCUS when performed by a gastroenterologist or a radiologist
POCUS will be performed by gastroenterologists or radiologist and outcomes on sensitivity/specificity will be compared between the two
Compare clinical disease activity scores when POCUS is used compared with standard of care
Using disease activity score questionnaires (HBI (If Crohn's disease) or SCCAI (If ulcerative Colitis)) at baseline and six months.
Compare use of steroids with POCUS compared with standard of care
Number of courses of steroids and total steroid dose over the duration of the trial
Compare haemaglobin levels when POCUS is used compared with standard of care
Are there significant difference between the change in haemaglobin from baseline to six months in the POCUS group compared with standard of care
Compare CRP levels when POCUS is used compared with standard of care
Are there significant difference between the change in CRP from baseline to six months in the POCUS group compared with standard of care
Compare Platelets when POCUS is used compared with standard of care
Are there significant difference between the change in platelets from baseline to six months in the POCUS group compared with standard of care
Compare Platelets when POCUS is used compared with standard of care
Are there significant difference between the change in albumin from baseline to six months in the POCUS group compared with standard of care

Full Information

First Posted
April 6, 2023
Last Updated
April 20, 2023
Sponsor
University College, London
search

1. Study Identification

Unique Protocol Identification Number
NCT05838196
Brief Title
Service Development of POCUS in the IBD Clinic
Official Title
Does the Use of Point of Care Ultrasound During Inflammatory Bowel Disease Clinic Appointments Change Management, Speed up Treatment Decisions and Save Money: a Feasibility and Service Development Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 24, 2023 (Anticipated)
Primary Completion Date
February 1, 2024 (Anticipated)
Study Completion Date
September 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University College, London

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Study to determine whether the use of an ultrasound completed during an inflammatory bowel disease (IBD) clinic will speed up diagnosis, treatment initiation, reduce complications, save money and reduce investigations compared with our current standard of care.
Detailed Description
After being provided with study information and providing written informed consent, participants attending the inflammatory bowel disease clinic will be randomised to standard of care or to receiving an ultrasound during the clinic appointment. This ultrasound result will be used to determine treatment decisions. Participants will have a 6 month follow-up to capture outcome data and further medical record review will be conducted at one year.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammatory Bowel Diseases
Keywords
Intestinal ultrasound

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
114 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
Participant will follow standard of care
Arm Title
Point-of-care Ultrasound
Arm Type
Experimental
Arm Description
Participant will receive point-of-care ultrasound at time of clinic appointment and clinician will use result to inform treatment decision
Intervention Type
Diagnostic Test
Intervention Name(s)
Point-of-care ultrasound
Intervention Description
Point-of-care ultrasound performed during clinic appointment
Primary Outcome Measure Information:
Title
Compare time to definitive IBD-related treatment initiation with the use of POCUS compared to standard of care
Description
Time in days for when a new medication is started, dose changed, medication stopped, or surgery performed following the clinic appointment
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Does point of care ultrasound change clinical decision making in the IBD clinic
Description
Does the clinical decision made before ultrasound differ from that following ultrasound.
Time Frame
Immediate
Title
Compare sensitivity and specificity of POCUS to identify active disease with standard of care investigations (MRI, ultrasound, endoscopy)
Description
Using formalised imaging or endoscopy as gold standard for determining disease activity, compare findings on POCUS to determine sensitivity and specificity
Time Frame
6 months
Title
Compare healthcare resource utilisation including outpatient appointments, need for further investigations and admissions in patients receiving POCUS or standard of care
Description
Using NHS cost tariffs, estimated costs for participants following standard of care to those receiving POCUS over the year following enrolment
Time Frame
1 year
Title
Compare findings at POCUS when performed by a gastroenterologist or a radiologist
Description
POCUS will be performed by gastroenterologists or radiologist and outcomes on sensitivity/specificity will be compared between the two
Time Frame
6 months
Title
Compare clinical disease activity scores when POCUS is used compared with standard of care
Description
Using disease activity score questionnaires (HBI (If Crohn's disease) or SCCAI (If ulcerative Colitis)) at baseline and six months.
Time Frame
6 months
Title
Compare use of steroids with POCUS compared with standard of care
Description
Number of courses of steroids and total steroid dose over the duration of the trial
Time Frame
1 year
Title
Compare haemaglobin levels when POCUS is used compared with standard of care
Description
Are there significant difference between the change in haemaglobin from baseline to six months in the POCUS group compared with standard of care
Time Frame
6 months
Title
Compare CRP levels when POCUS is used compared with standard of care
Description
Are there significant difference between the change in CRP from baseline to six months in the POCUS group compared with standard of care
Time Frame
6 months
Title
Compare Platelets when POCUS is used compared with standard of care
Description
Are there significant difference between the change in platelets from baseline to six months in the POCUS group compared with standard of care
Time Frame
6 months
Title
Compare Platelets when POCUS is used compared with standard of care
Description
Are there significant difference between the change in albumin from baseline to six months in the POCUS group compared with standard of care
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 16 years or above Attending IBD clinic face-to-face Able to give informed consent. Belonging to one of the following groups: New patients with high clinical suspicion of IBD Known UC/IBD-U and possible flare Known Crohn's and possible flare Known IBD and assessing response to a new medication or following surgery Known IBD and clinician planning endoscopic or radiological investigations Exclusion Criteria: Inflammatory bowel disease limited to proctitis with no clinical suspicion of extension
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
William Blad, BM BCh
Phone
+447841581873
Email
william.blad@nhs.net
First Name & Middle Initial & Last Name or Official Title & Degree
Jessica Broni-Tabi
Email
jessica.broni-tabi1@nhs.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
William Blad, BM BCh
Organizational Affiliation
University College London Hospitals Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
University College London Hospitals NHS Trust
City
London
ZIP/Postal Code
NW1 2PG
Country
United Kingdom
Individual Site Status
Recruiting

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Service Development of POCUS in the IBD Clinic

We'll reach out to this number within 24 hrs